Trinity compound research profile
Teriparatide
Teriparatide is a lab-made copy of the first 34 building blocks (amino acids) of a much longer natural hormone called parathyroid hormone, which your body...
Research overview
Teriparatide is a lab-made copy of the first 34 building blocks (amino acids) of a much longer natural hormone called parathyroid hormone, which your body uses to control calcium and bone health. It's sold under brand names like Forteo and is made using genetic engineering technology (recombinant DNA) rather than being extracted from a natural source (PubChem).
Mechanism under study
Here's something surprising: too much parathyroid hormone all the time actually breaks bone down, but tiny, once-daily doses of teriparatide flip the script and build new bone instead. It's like the difference between constantly nagging someone (which wears them down) versus a quick daily reminder (which motivates them to build something). This once-a-day dosing pattern triggers bone-building cells to activate, while also affecting how your kidneys handle calcium and phosphate (StatPearls).
Human evidence summary
In a major clinical trial of over 1,600 women with osteoporosis who'd already had a spine fracture, those on daily teriparatide injections had far fewer new spine fractures compared to those on a placebo (fake treatment): about 5% got a new fracture on the lower dose versus 14% on placebo. Bone density in the spine went up by about 9 percentage points (Neer et al., NEJM 2001). Nausea and headache were the most common downsides.
Preclinical evidence summary
In rats given the drug over their entire two-year lifespan at various doses, some developed a type of bone cancer called osteosarcoma. This raised concern initially, but 15 years of monitoring people who actually take the drug hasn't shown the same cancer risk in humans (StatPearls).
Source material
Use the linked publications and records to evaluate study design, population, limitations, and relevance.